svpn news
reuters.com ↗
ArriVent BioPharma said on Tuesday its therapy to treat patients with a type of lung cancer did not meet the main goal in a late-stage trial.
Log in or sign up to comment.
No comments yet.
← Back to stories
Log in or sign up to comment.